NP_445788.2
[Other Products]
NCBI GenBank Nucleotide #
|
[Other Products]
UniProt Related Accession #
Molecular Weight
42,664 Da
NCBI Official Full Name
advanced glycosylation end product-specific receptor
NCBI Official Synonym Full Names
advanced glycosylation end product-specific receptor
NCBI Official Synonym Symbols
NCBI Protein Information
advanced glycosylation end product-specific receptor
UniProt Protein Name
Advanced glycosylation end product-specific receptor
UniProt Synonym Protein Names
Receptor for advanced glycosylation end products
UniProt Synonym Gene Names
UniProt Entry Name
RAGE_RAT
NCBI Summary for AGER
cell surface receptor for various molecules, including the amyloidogenic form of serum amyloid A [RGD, Feb 2006]
UniProt Comments for AGER
RAGE: Mediates interactions of advanced glycosylation end products (AGE). These are nonenzymatically glycosylated proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes. Acts as a mediator of both acute and chronic vascular inflammation in conditions such as atherosclerosis and in particular as a complication of diabetes. AGE/RAGE signaling plays an important role in regulating the production/expression of TNF- alpha, oxidative stress, and endothelial dysfunction in type 2 diabetes. Interaction with S100A12 on endothelium, mononuclear phagocytes, and lymphocytes triggers cellular activation, with generation of key proinflammatory mediators. Interaction with S100B after myocardial infarction may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling. Receptor for amyloid beta peptide. Contributes to the translocation of amyloid-beta peptide (ABPP) across the cell membrane from the extracellular to the intracellular space in cortical neurons. ABPP-initiated RAGE signaling, especially stimulation of p38 mitogen-activated protein kinase (MAPK), has the capacity to drive a transport system delivering ABPP as a complex with RAGE to the intraneuronal space. Interacts with S100B, S100A1 and APP. Interacts with S100A12. Endothelial cells. 4 isoforms of the human protein are produced by alternative splicing.
Protein type: Receptor, misc.; Motility/polarity/chemotaxis; Membrane protein, integral; Cell cycle regulation
Cellular Component: extracellular space; cell surface; cell soma; axon; cytoplasm; basal plasma membrane; integral to membrane; plasma membrane; extracellular region; cytosol
Molecular Function: heparin binding; identical protein binding; protein binding; advanced glycation end-product receptor activity
Biological Process: positive regulation of JNK activity; glycoprotein metabolic process; positive regulation of apoptosis; negative regulation of collagen biosynthetic process; positive regulation of smooth muscle cell proliferation; negative regulation of cell adhesion; positive regulation of smooth muscle cell migration; activation of NF-kappaB transcription factor; response to vitamin A; induction of positive chemotaxis; calcium ion homeostasis; positive regulation of fibroblast proliferation; connective tissue replacement during inflammatory response; negative regulation of protein amino acid phosphorylation; regulation of DNA binding; positive regulation of neuron apoptosis; response to methylglyoxal; inflammatory response; positive regulation of autophagy; neurite development; response to fructose stimulus; JAK-STAT cascade; astrocyte development; response to genistein; response to hyperoxia; negative regulation of endothelial cell proliferation; regulation of inflammatory response; response to hypoxia; negative regulation of osteoblast proliferation; response to activity; brain development; positive regulation of protein amino acid phosphorylation; positive regulation of phagocytosis, engulfment; positive regulation of inflammatory response; positive regulation of cell migration; lung development
Research Articles on AGER
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice. It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Products associated with AGER clia kit
Pathways associated with AGER clia kit
Organs/Tissues associated with AGER clia kit
|